CBD Oracle, a cannabis consumer research company, released the first publicly available, attorney-reviewed state-by-state map detailing the legality of delta-8 THC in the U.S.
The map, designed to illuminate the intricate legal landscape surrounding delta-8 THC, serves as a valuable resource for the hemp industry and consumers.
See Also: DEA Weighs In On Legality Of THCA, Delta-8 And Other Minor Cannabinoids
It intends to assist both the hemp industry and consumers in navigating these intricate legal requirements.
Attorney Neil Willner, co-chair of the cannabis group at Royer Cooper Cohen Braunfeld, worked alongside CBD Oracle to examine the laws of each state and federal regulations, ensuring the map's accuracy. According to Willner, having precise information is crucial in an industry as dynamic as cannabis.
About The Analysis
- The analysis, per a press release, revealed that 17 U.S. states have banned delta-8 THC, with seven others imposing severe restrictions on its sale.
- The prohibitions in states like Colorado, Nevada and North Dakota often target the "isomerization" process used to convert CBD into delta-8 THC.
- Meanwhile, states like California and Maryland only allow delta-8 THC within the regulated marijuana industry. In contrast, 21 states and Washington D.C. consider delta-8 THC to be broadly legal.
- However, only a few of these states, namely Alabama, Florida, Kentucky and Wyoming, have laws specifying that delta-8 THC should only be sold to adults.
Read the full analysis HERE.
Did you miss the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth. Join Benzinga PotProfits. Benefit from Michael Berger’s sharp analysis, revealing top cannabis stock opportunities and timely updates. Experience the potential of 10%+ returns in just 90 days. Our 4.5-star Marketfy rating speaks volumes. Secure your position in this booming sector with a 30-day money-back guarantee. The time to invest is now before everyone else realizes it. Secure your profits with Benzinga. Click here now to learn more.
Read Next: THC Obsession: What Really Matters When Choosing Cannabis Cultivars
Image by Benzinga
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.